Scotts Miracle-Gro Co (SMG): what the price assumes

In the published model solve dated 2026-Q2, anchored at $66.14, Scotts Miracle-Gro Co (SMG) is priced for +4.9% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-11.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/SMG

Headline

FieldValue
TickerSMG
CompanyScotts Miracle-Gro Co
Sector / IndustryBasic Materials
Current price$66.14/sh
CompositionU.S. Consumer - Growing media and mulch 40% / U.S. Consumer - Lawn care 27% / U.S. Consumer - Controls 12% / U.S. Consumer - Roundup marketing agreement 5% / U.S. Consumer - Other, primarily gardening 5% / Hawthorne - Nutrients 2% / Hawthorne - Lighting 2% / Hawthorne - Growing media 1% / Hawthorne - Other, primarily hardware and growing environment 1% / Other - Growing media 3% / Other - Lawn care 2% / Other - Other, primarily gardening and controls 2%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)7.3%
Operating margin today12.5%
Margin compression (value-band)-5.2pp
Implied growth4.9%
Multiple paid15x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.9% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6.1pp.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.35σ
cohort percentile (of 77 peers)29
implied end-window share0%

Valuation X-Ray

Every valuation family lands below the price. The price therefore sits beyond what those standard frames encode.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset0
Earnings3.72x2expensive
Relative0
Growth2.15x2expensive

Families that call it expensive: Earnings, Growth

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 5.8%); the inversion above states its own rate.

Per-Model Detail (n=4)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$72.990.91xnoFCF base $0.4B, growth -2% (input: historical growth), terminal g 0.5%, WACC 5.8%, 5yr projection
DCF Exit MultipleGrowth$79.780.83xnoExit EV/EBITDA: 12.3x / 14.3x / 16.3x (bear / base = today's held flat / bull), 5yr
Relative ValuationRelativenoP/E 20.38x (blended: static sector reference 14x + trailing (TTM) 35x), scenarios: 17.2x / 20.4x / 23.5x (bear / base = reference held flat / bull), EV/EBITDA 9.88x
Simple DDMGrowth$28.902.29xyesDPS $2.67, g=0.0% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$32.972.01xyesStage 1: -5% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAssetno
Two-Stage Excess ReturnAssetno
Discounted Future Market CapGrowth$43.631.52xnoRev $3.4B, growth -2% (input: historical growth; tapered), Terminal P/S: 1.0x / 1.2x / 1.3x (bear / base = today's held flat / bull, cap 8x)
Growth-Adjusted P/ERelativeno
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$29.142.27xnoNormalized EBIT (5y avg op income, one-time charges added back) $0.34B × (1−28%) / WACC 5.8% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativenoEBITDA $0.46B × sector EV/EBITDA 8.0x
FCF YieldEarnings$24.462.70xyesFCF $379.7M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$13.994.73xyesSBC-adj FCF $0.32B (FCF $0.38B − SBC $0.06B) capitalized at Kₑ
Ben Graham FormulaEarnings$1.5442.95xyesEPS $1.84 × (8.5 + 2×-4.9%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAssetno
P/Sales SectorRelativenoRevenue $3.39B × sector P/S 1.5x
PEG Fair ValueRelativeno
Earnings YieldEarnings$19.893.33xnoEPS $1.84 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
U.S. Consumeroperatingenterprise3.0B reported-currencywithheldunresolved no unit value
Hawthorneoperatingenterprise0.2B reported-currencywithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$2.4b
Net debt / NOPAT (after-tax)7.51x
Net debt / operating income (pre-tax)5.42x
Interest coverage3.7x
Share count CAGR (dilution)1.4%
Burning cashno

Bullet Takeaways

Bull Case

Scotts Miracle-Gro just finished a multi-year capital-allocation repair job, and the exit velocity is visible in every line. The Hawthorne hydroponics business, the acquisition spree that loaded the balance sheet, was classified held-for-sale and sold in April 2026 to Vireo Growth in a share exchange. Net leverage fell to 3.71 times debt-to-EBITDA, below 4 times for the first time in four years and down from 4.41 a year earlier, and management has pointed to the previously announced multi-year share repurchase program as the next use of the freed cash flow. Through it all the company kept paying $0.66 per quarter, about a 4% yield at today's $65.43 (July 2026). Sell the distraction, pay down the debt, keep the dividend, then buy back stock: it is the whole capital-allocation textbook in one sequence.

What remains after the divestiture is the business Scotts should arguably always have been: the dominant US consumer lawn and garden franchise. The peak-season quarter delivered revenue of $1.46 billion, up 2.8% and $60 million past projections, with non-GAAP earnings of $4.53 per share beating by $0.51 and gross margin improving 240 basis points to 41.8%. The model is brand-driven demand creation; the 10-K describes marketing built on "providing innovative and differentiated products and continually increasing brand and product awareness to inspire consumers to create retail demand" (FY2025 10-K, accession 0000825542-25-000022), and the newest channel is compounding fastest, with e-commerce point-of-sale dollars up 22% year to date.

The price still carries the scars of the Hawthorne era rather than the shape of what emerged. The market pays about 7 times operating income on the pricing framework's basis, below what even a 5% annual decline in operating profit would warrant. Against reaffirmed fiscal 2026 adjusted earnings guidance of $4.15 to $4.35 per share, today's price is roughly 15 times, an ordinary consumer-staples multiple for a category leader with margin recovery, a new CEO installed in June 2026 to run the operational next chapter, and deleveraging converting enterprise value into equity value every quarter.

Bear Case

This is a seasonal, weather-hostage business sold through two customers, and the cycle risks compound rather than diversify. The 10-K is explicit on both counts: annual net sales are "further concentrated in the second and third fiscal quarters by retailers who rely on our ability to deliver products closer to when consumers buy our products", and "The Home Depot and Lowe's are our two largest customers and are the only customers that individually represent more than 10% of reported consolidated net sales during any of the three most recent fiscal years" (FY2025 10-K, accession 0000825542-25-000022). A wet spring, a soft housing market, or a single retailer deciding to run leaner seasonal inventory flows straight through the P&L, and the filing concedes the pricing lever is not free: "Our projections may not accurately predict the volume impact of price increases" (accession 0000825542-25-000022). The current year's beat was earned in the season's easy half; the June quarter, when sell-through either validates retailer orders or becomes fall returns, is where lawn-and-garden years go to die.

The reported numbers still need untangling before the cheapness claim survives contact. Trailing GAAP earnings run $1.84 per share (about 35 times at today's price), while the guided adjusted figure is $4.15 to $4.35; the gap is Hawthorne wind-down charges and other adjustments, and the same split shows up in operating income, where the EDGAR trailing tally reads $445 million against the pricing framework's $945 million record basis, a divergence past 100%. Every method that anchors to the GAAP trailing year finds the stock expensive: earnings-based reads land around a quarter of the price, cash-flow capitalization under half, and even the dividend-growth models land near $29 to $33 because the payout barely grew through the leverage years. The cheap story requires trusting the adjusted numbers as the real run-rate; the expensive story requires only reading the statements as filed.

The balance sheet, though improving, still disciplines everything. Net debt of about $2.36 billion runs 5.3 times the EDGAR-basis trailing pre-tax operating income with interest covered just 3.8 times, and cash on hand at quarter-end was thin. The dividend costs roughly $150 million a year, the buyback program now competes for the same cash, and a leadership transition after decades under one CEO adds execution uncertainty exactly when the company is promising a shareholder-friendly turn. If the post-Hawthorne run-rate disappoints, or one bad spring interrupts the deleveraging path, the multiple the bulls quote applies to earnings that never materialize.

Valuation

Two operating-income bases coexist and must be named before any multiple means anything: the pricing framework's record basis carries trailing operating income of about $945 million, while the EDGAR quarterly tally reads $445 million, a divergence past 100% created mostly by Hawthorne wind-down and other charges landing in the GAAP line. On the record basis the market pays about 7 times operating income, below what even a 5% annual operating-profit decline would warrant; on the GAAP trailing base the same price is a premium multiple. Management's own reconciliation of the year is the guided adjusted earnings of $4.15 to $4.35 per share, which puts $65.43 (July 2026) at roughly 15 times forward adjusted earnings against trailing GAAP earnings of $1.84.

The method families, which run on the GAAP statements, uniformly fail to reach the price: earnings-capitalization reads land around a quarter of it, blended relative multiples about half, and the dividend-discount reads near $29 to $33 on the $2.67 annual payout. No family justifies the price on trailing GAAP numbers, which is the honest description of what a buyer at today's level is doing: paying for the post-divestiture run-rate, not the transition-year statements. The evidence for that run-rate so far: peak-quarter revenue of $1.46 billion (up 2.8%, $60 million above projections), gross margin of 41.8% (up 240 basis points), and reaffirmed full-year guidance. The Hawthorne sale closed in April 2026, so fiscal 2027 becomes the first clean year of the US Consumer pure play.

Solvency is the improving constraint. Net debt of about $2.36 billion sits at 5.3 times the EDGAR-basis trailing pre-tax operating income with 3.8 times interest coverage, but the company's own leverage covenant math, 3.71 times debt-to-EBITDA and falling from 4.41, reads much healthier because it runs on adjusted earnings before the wind-down charges. The share count has been roughly flat (up 1.4% a year), the $0.66 quarterly dividend yields about 4%, and the repurchase program waits on continued deleveraging. The decisive question the price poses is single and testable: is $4.15 to $4.35 the real earning power of the remaining business? The June-quarter sell-through data answers most of it.

Catalysts

The transformation events have already landed this year; what remains is proof. The Hawthorne Gardening Company sale to Vireo Growth completed in April 2026, paid in Vireo shares held among other investments, ending the hydroponics experiment and leaving a US Consumer pure play plus a Canadian business. In late June 2026 the board appointed Nathan E. Baxter as president and CEO, closing out Jim Hagedorn's decades-long run, and reaffirmed fiscal 2026 guidance alongside the transition. New-CEO capital-allocation signals (buyback pace, portfolio moves, cost programs) are the discretionary catalysts from here.

The operating calendar peaks now. The April 29 second-quarter report delivered the season's setup: revenue of $1.46 billion (up 2.8%, $60 million above projections), non-GAAP EPS of $4.53 (a $0.51 beat), 41.8% gross margin, e-commerce point-of-sale dollars up 22% year to date, and reaffirmed full-year guidance of low single-digit US Consumer sales growth and $4.15 to $4.35 in adjusted EPS. The fiscal third-quarter report, on the usual early-August cadence, covers the June quarter where consumer sell-through either confirms the retailer orders already shipped or shows up as weak point-of-sale and elevated returns; for a company whose year is two quarters long, it is the season's verdict.

The balance-sheet track has its own milestones: leverage at 3.71 times debt-to-EBITDA, below 4 for the first time in four years, the $0.66 quarterly dividend (most recently paid June 5, 2026), and the multi-year repurchase authorization that activates in earnest as leverage falls. Each quarter-turn of deleveraging transfers enterprise value to the equity; a leverage print starting with a 3.3 or lower alongside maintained guidance would be the cleanest re-rating trigger on the board.

Peer Cohorts (Per Segment, With Filing Citations)

U.S. Consumer (reported)

Hawthorne (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Q2 FY2026 disclosures and completion announcement, 2026 · Q2 FY2026 earnings materials, April 29, 2026 · dividend declaration, 2026 · Q2 FY2026 earnings release, April 29, 2026 · Q2 FY2026 earnings call, April 2026 · leadership announcement, June 2026 · Q2 FY2026 earnings materials, April 2026 · Hawthorne sale completion announcement, 2026 · Q2 FY2026 earnings release and call, April 29, 2026 · dividend declaration, May 2026

View the full interactive SMG report on boothcheck